Skip to content

Nasal High-frequency Oscillatory Ventilation (NHFOV) for Ventilated Newborn Infants With BPD

Nasal High-frequency Oscillatory Ventilation (NHFOV) vs Nasal Continuous Positive Airway Pressure(NCPAP) for Ventilated Newborn Infants With BPD: a Randomized Controlled Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04905732
Enrollment
200
Registered
2021-05-28
Start date
2021-05-20
Completion date
2024-12-31
Last updated
2022-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bronchopulmonary Dysplasia, Nasal Continuous Positive Airway Pressure, Nasal High-frequency Oscillatory Ventilation, Neonate

Brief summary

Invasive ventilation(IV) remains one key cornerstone to reduce neonatal mortality for preterm infants with respiratory distress syndrome(RDS) and/or acute respiratory distress syndrome(ARDS). However, it is also related to increased risks of ventilator-associated lung injury and escalation of pulmonary inflammation, and which finally result in bronchopulmonary dysplasia (BPD). Early weaning from IV in newborn infants with BPD is therefore a key procedure to reduce these risks above.

Detailed description

Supplying with the combined advantages of NCPAP and high-frequency oscillatory ventilation (HFOV) with high carbon dioxide(CO2) removal, no need for synchronisation, non-invasion, less volume/barotraumas, and increased functional residual capacity, nasal HFOV(NHFOV) was considered as a strengthened version of NCPAP. Furthermore, the superimposed oscillations of NHFOV could avoid gas-trapping, and allowed to obviously up-regulate mean airway pressure (MAP) more than NCPAP. Thus, NHFOV might be more beneficial as post-extubation respiratory support strategy to avoid re-intubation and subsequent complications and/or sequelae as compared with NCPAP in preterm infants. Nowadays, NHFOV was increasingly used in neonatal intensive care unit (NICU) around the world due to its convenient operation. A retrospective review has reported the beneficial effects of NHFOV in preterm infants as a remedial measure after failing to other noninvasive modes, including reducing the number of apneas, bradycardias or oxygen desaturations. However, there were rare randomized controlled studies comparing NHFOV with NCPAP in preterm infants with BPD. We have found that NHFOV is superior to NCPAP in avoiding re-intubation in very preterm infants with the first extubation. The purpose of the present study was to compare NHFOV with NCPAP as post-extubation respiratory support strategies on the need for endotracheal ventilation, as well as pressure of CO2(PCO2) level in preterm infants with BPD.

Interventions

DEVICENHFOV

After documenting parental consent, the ventilated infants with BPD were randomly assigned to NHFOV

DEVICENCPAP

After documenting parental consent, the ventilated infants with BPD were randomly assigned to NCPAP

Sponsors

Children's Hospital of Chongqing Medical University
CollaboratorOTHER
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Investigator, Outcomes Assessor)

Masking description

After documenting parental consent, these ventilated infants with BPD were randomly assigned to either NHFOV or NCPAP using a table of random numbers and sealed opaque envelopes when they were eligible for extubation. Blinding to doctor was not possible due to the nature of the intervention, is not necessary to participant.

Intervention model description

After documenting parental consent, the ventilated infants with BPD were randomly assigned to either NHFOV or NCPAP

Eligibility

Sex/Gender
ALL
Age
28 Days to 6 Months
Healthy volunteers
No

Inclusion criteria

Eligibility requirements for neonates: * The gestational age is less than 32 weeks * The preterm neonates are diagnosed with BPD and need invasive ventilation * Extubation and subsequent noninvasive ventilation is ready to be carried out

Exclusion criteria

one of the following conditions is needed: * there were no intraventricular hemorrhage(IVH) grades 3 or 4 * major congenital anomalies * parents' decision not to participate

Design outcomes

Primary

MeasureTime frameDescription
re-intubation rateseven days after extubationthe newborn infants with ventilated BPD is reintubated after extubation
deathseven days after extubationthe newborn infants with BPD die
the level of carbon dioxideseven days after extubationthe level of carbon dioxide is measure after extubation between groups

Secondary

MeasureTime frameDescription
necrotizing entercolitis(NEC)seven days after extubationthe newborn infants with BPD is diagnosed with NEC
intraventricular hemorrhage(IVH)seven days after extubationthe newborn infants with BPD is diagnosed with NEC

Countries

China

Contacts

Primary ContactChen(陈) Long, MD, PhD
neuroclong@126.com+8613883559467

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026